Desensitization in Kidney Transplantation

• Status: Completed
• Trial end date: 2012-11-01

Summary

To determine if deletional strategies will provide effective desensitization.

• Phase: Phase 4

Details

• Lead Sponsor: University of Cincinnati
• Collaborator: Millennium Pharmaceuticals, Inc.
• Treatments: Bortezomib; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Rituximab